Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Relapse Rate After 12 Weeks Verses 20 Weeks Steroid Therapy for the Management of First Episode of Steroid Sensitive Nephrotic Syndrome: A Randomized Control Trial at Children Hospital, Pakistan Institute of Medical Sciences, Islamabad

NCT04713410 is registered in ClinicalTrials.gov with Shaheed Zulfiqar Ali Bhutto Medical University as lead sponsor.

NCT NCT04713410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04713410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Relapse Rate After 12 Weeks Verses 20 Weeks Steroid Therapy for the Management of First Episode of Steroid Sensitive Nephrotic Syndrome: A Randomized Control Trial at Children Hospital, Pakistan Institute of Medical Sciences, Islamabad
Lead sponsor
Shaheed Zulfiqar Ali Bhutto Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
December 22, 2020
Completion date
September 4, 2023
Enrollment
68 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

steroid-sensitive nephrotic syndrome